Ambani’s oxygen helps 15 lakh patients in April alone; all for free

1st May 2021

1st May 2021

To save more lives, Mukesh Ambani-led Reliance Industries (RIL) has risen to the occasion and has become India’s largest single-location producer of medical-grade liquid oxygen amid challenging times. The organization has diverted its resources to quickly ramp up the production of medicinal oxygen from 0 to 1000 MT per day free of charge.

“Traditionally, Reliance is not a manufacturer of medical-grade liquid oxygen. Yet, starting from nil before the pandemic, Reliance Industries has now become India’s largest producer of this life-saving resource from a single location,” RIL said in a media statement.

"In April 2021, Reliance supplied over 15,000 MT of medical-grade liquid oxygen free of cost, helping nearly 15 lakh patients," the statement read.

It first started with 100 MT oxygen per day which was sent to Maharashtra. Later on, the production was increased to 700 MT per day and was sent to other states like Madhya Pradesh and Gujarat. Now the company has said that their medical oxygen production has been increased to 1000 MT per day.

The company also informed about the transportation of oxygen and said that Reliance has airlifted 24 ISO (certified by the International Organization for Standardization) containers for transporting medical-grade liquid oxygen and will soon get more ISO containers in the next few days

Commenting on these initiatives, Mukesh Ambani said, "For me and all of us at Reliance, nothing is more important than saving every life as India battles against a new wave of the COVID-19 pandemic. There is an immediate need to maximize India's production and transportation capacities for medical-grade oxygen. I am proud of our engineers at Jamnagar who have worked tirelessly, with a great sense of patriotic urgency, to meet this new challenge”

Besides this, Mukesh Ambani-led Reliance Industries Limited (RIL) will also set up a 1,000-bed hospital with an oxygen supply facility in Gujarat’s Jamnagar.

 

Number of Reads: 13

2021 Newsbred© All Rights Reserved.

Support Us X

Contribute to see NewsBred grow. And rejoice that your input has made it possible.

Contribute to see NewsBred grow.X